3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
PHASE2CompletedINTERVENTIONAL
Enrollment
39
Participants
Timeline
Start Date
January 31, 2004
Primary Completion Date
March 31, 2007
Conditions
Adenocarcinoma of the EsophagusRecurrent Esophageal CancerStage IV Esophageal Cancer
Interventions
DRUG
triapine
Given IV
DRUG
cisplatin
Given IV
Trial Locations (1)
60637-1470
University of Chicago Comprehensive Cancer Center, Chicago
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00077545 - 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction | Biotech Hunter | Biotech Hunter